LTR Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: LTP only recently listed within the past 12 months

Top 22 shareholders own 52.48% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
30.2%	LTR medical Pty Ltd	46,373,750	AU$56.3m	0%	no data
3.86%	Strategic Drug Solutions Inc	5,933,000	AU$7.2m	0%	no data
2.72%	Trexapharm Inc	4,188,000	AU$5.1m	0%	no data
1.59%	Go Medical Industries Pty. Ltd.	2,443,000	AU$3.0m	0%	no data
1.42%	Jason Rich	2,187,500	AU$2.7m	0%	no data
1.37%	Lee Rodne	2,111,784	AU$2.6m	0%	no data
1.14%	Wolseley Road 1 Pty Limited	1,747,500	AU$2.1m	19.9%	no data
1.02%	Alium Capital Management Pty Ltd	1,562,500	AU$1.9m	0%	43.22%
1%	Monil Shah	1,537,813	AU$1.9m	0%	no data
0.98%	Parkview Sc Bio Llc	1,500,000	AU$1.8m	-64.7%	no data
0.92%	Philip Cawood	1,420,179	AU$1.7m	-38.8%	no data
0.74%	Fredronn Pty Ltd	1,144,250	AU$1.4m	-7.77%	no data
0.73%	HGL Investments Pty Ltd	1,125,000	AU$1.4m	0%	no data
0.73%	Danny Zanardo	1,122,135	AU$1.4m	0%	no data
0.67%	Peter Wade	1,034,081	AU$1.3m	-5.07%	no data
0.63%	David Hannon	970,000	AU$1.2m	0.78%	no data
0.62%	Tempest Dawn Pty Ltd	960,000	AU$1.2m	-16%	no data
0.59%	Cityscape Asset Trust	911,000	AU$1.1m	0%	no data
0.53%	Julian Chick	808,492	AU$982.3k	0%	no data
0.45%	Jacques Schipper	698,000	AU$848.1k	0%	no data
0.45%	Iaa Consulting Inc	698,000	AU$848.1k	0%	no data
0.15%	Maja McGuire	235,492	AU$286.1k	0%	no data